| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PROS.20311 |
| P698 | PubMed publication ID | 16372331 |
| P2093 | author name string | Ib Jarle Christensen | |
| Julia S Johansen | |||
| Paul A Price | |||
| Patrick Garnero | |||
| Peter Iversen | |||
| Klaus Brasso | |||
| Børge Teisner | |||
| P433 | issue | 5 | |
| P921 | main subject | Chitinase 3 like 1 | Q21117210 |
| metastatic prostate carcinoma | Q55779807 | ||
| P304 | page(s) | 503-513 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma | |
| P478 | volume | 66 |
| Q57826829 | An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis |
| Q39700712 | Association between YKL-40 and adult primary astrocytoma |
| Q36568996 | Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation |
| Q38034435 | Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group |
| Q47112547 | Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study |
| Q34960867 | Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions |
| Q37665099 | CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors |
| Q28586972 | Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells |
| Q35168063 | Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia |
| Q99417962 | Chitinase-3 like-protein-1 function and its role in diseases |
| Q38726476 | Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients |
| Q38766102 | Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons. |
| Q36491529 | Does estrogen play a role in response to adjuvant bone-targeted therapies? |
| Q34052057 | Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells |
| Q43011817 | Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer |
| Q37402732 | Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer |
| Q34023877 | Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer |
| Q37280948 | Human chitinases and chitinase-like proteins as indicators for inflammation and cancer |
| Q33942238 | In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases |
| Q38903303 | New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma |
| Q26853189 | Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer |
| Q24656942 | Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells |
| Q35647254 | Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer |
| Q81295804 | Prostate cancer |
| Q36487174 | Prostate cancer survival in Trinidad: Is PSA a prognostic factor? |
| Q33732189 | Resveratrol represses YKL-40 expression in human glioma U87 cells |
| Q37218904 | Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers |
| Q37218917 | Serum YKL-40 Levels in Patients with Gastric Cancer |
| Q93377974 | Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk |
| Q58786224 | Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma |
| Q35844765 | Use of urinary markers in cancer setting: A literature review |
| Q36959180 | Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study |
| Q34494109 | Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies |
| Q36516278 | Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors. |
| Q33343967 | YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor |
| Q39797155 | YKL-40, a secreted glycoprotein, promotes tumor angiogenesis |
| Q37334247 | YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? |
| Q53204820 | YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. |
Search more.